Pacific Biosciences of California, Inc.
PACB Real Time Price USDRecent trades of PACB by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in PACB holdings by institutional investors
Quarterly net insider trading by PACB's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$60,000 Oct 20, 2022 Issue: Health Issues
-
$60,000 Oct 19, 2022 Issue: Health Issues
-
$60,000 Jul 20, 2022 Issue: Health Issues
-
$60,000 Jul 19, 2022 Issue: Health Issues
-
$60,000 Apr 20, 2022 Issue: Health Issues
-
$50,000 Apr 19, 2022 Issue: Health Issues
-
$50,000 Jan 20, 2022 Issue: Health Issues
-
$50,000 Jan 19, 2022 Issue: Health Issues
-
$50,000 Oct 20, 2021 Issue: Health Issues
-
$50,000 Oct 20, 2021 Issue: Health Issues
-
$20,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$20,000 Jul 20, 2021 Issue: Health Issues
Former government officials who have lobbied for PACB
19 former government officials from 16 congressional offices at 2 lobbying firms have lobbied for PACB, most recently Oct 20, 2021.
-
Zachary Mallove Senate New Sr Pol Adv, LA, Leg. Aide (Senator Murray); Leg. Aide, Joint Comm on Deficit Reduc. -
Dean Rosen Senate New Health Pol Dir (Senate Maj Ldr Frist); Staff Dir (Senate Pub. Health SC); Maj Health Pol Csl (House Ways/Means C, Health SC); Health Pol Coord & Csl (Senate Labor/HR C); Csl & Prof Staff (Senate Labor/HR C, Disab Pol SC); Case Wkr (Rep. Boschwitz) -
David Thomas House New CoS (Rep. Lofgren); Dir of Congressional Relations (FTC); Dep Dir for Legis Affairs (Office of VP Gore); Staff Asst (Sen. Metzenbaum) -
Elise Finley Pickering House New Exec Dir (House Repub Pol C); CoS (Rep. Shadegg); LA (Rep. Dannemeyer); LD (Rep. Bartlett) -
Bruce Mehlman House New Asst Sec of Commerce for Tech Pol; General Csl & Pol Dir (House Repub Conf)
-
Sage Eastman House New Strategy Dir, Dep Staff Dir (Maj), Sr Adv (House Ways/Means C); Comm Dir (Rep. Camp) -
Steve Haro Senate New CoS (Sen. Feinstein); Asst Sec of Commerce for Leg & Intergovt Affairs; CoS (Sen. Heinrich); CoS (Rep. Heinrich); Sr Adv (Rep. Becerra); Dir of Legis & Comm (Rep. Becerra); Press Sec (Rep. Becerra) -
Lauren Aronson House New Dir (Office of Legis, CMS); Prof Staff Mem, (House Ways/Means C); Pol Dir (White House); Pol Dir (HHS Office of Health Reform-detailed to White House); Pol Adv (Rep. Emanuel); Health LA (Rep. McCarthy)
PACB Estimated quarterly lobbying spending
PACB Revenue by Segment or Geography
New PACB patent grants
-
Patent Title: Sequencing device Apr. 15, 2025
-
Patent Title: Recombinant polymerases with increased phototolerance Jul. 02, 2019
-
Patent Title: Recombinant polymerases with increased phototolerance Dec. 25, 2018
-
Patent Title: Nanopore sequencing using ratiometric impedance Oct. 02, 2018
-
Patent Title: Protected fluorescent reagent compounds May. 01, 2018
-
Patent Title: Methods of sequencing and identifying the position of a modified base in a nucleic acid Apr. 24, 2018
-
Patent Title: Polymerases for nucleotide analogue incorporation Apr. 24, 2018
-
Patent Title: Arrays of integrated analytical devices and methods for production Apr. 17, 2018
-
Patent Title: Analytical devices having dichroic prism arrays Apr. 17, 2018
-
Patent Title: Articles having localized molecules disposed thereon and methods of producing same Apr. 17, 2018
-
Patent Title: Functionalized cyanine dyes (peg) Mar. 20, 2018
-
Patent Title: Arrays of integrated analytical devices Mar. 13, 2018
-
Patent Title: Sequencing using concatemers of copies of sense and antisense strands Mar. 06, 2018
-
Patent Title: Modular nucleotide compositions and uses therefor Jan. 30, 2018
-
Patent Title: Methods and compositions for nucleic acid sample preparation Jan. 30, 2018
-
Patent Title: Recombinant polymerases for incorporation of protein shield nucleotide analogs Jan. 23, 2018
-
Patent Title: Single-molecule capacitive nucleic acid sequencing with nanoscale electrode pairs Jan. 16, 2018
-
Patent Title: Integrated analytical system and method Nov. 21, 2017
-
Patent Title: Molecular adaptors for dye conjugates Oct. 03, 2017
-
Patent Title: Nanopore sequencing using n-mers Sep. 26, 2017
-
Patent Title: Recombinant polymerases with increased phototolerance Sep. 12, 2017
-
Patent Title: Packaging methods for fabrication of analytical device packages and analytical device packages made thereof Sep. 05, 2017
-
Patent Title: Real-time analytical methods and systems Aug. 29, 2017
-
Patent Title: Nucleic acid sequence analysis Aug. 22, 2017
-
Patent Title: Molecular redundant sequencing Aug. 15, 2017
-
Patent Title: Photodamage mitigation compounds and systems Aug. 15, 2017
-
Patent Title: Substrates and optical systems and methods of use thereof having a single optically resolvable immobilized reaction component disposed within a nanometer-scale aperture Aug. 01, 2017
-
Patent Title: Recombinant polymerases for improved single molecule sequencing Aug. 01, 2017
-
Patent Title: Apparatus and method for performing nucleic acid analysis Jul. 18, 2017
-
Patent Title: Real-time electronic sequencing Jul. 18, 2017
-
Patent Title: Scaffold-based polymerase enzyme substrates Jul. 11, 2017
-
Patent Title: Process for making high multiplex arrays Jun. 27, 2017
-
Patent Title: Bis-biotinylation tags Jun. 13, 2017
-
Patent Title: Arrays of integrated analytical devices and methods for production May. 23, 2017
-
Patent Title: Enzymes resistant to photodamage May. 16, 2017
-
Patent Title: Sequencing reactions with lithium for pulse width control May. 16, 2017
-
Patent Title: Charged triplet-state quenchers for mitigation of photo-induced damage May. 02, 2017
-
Patent Title: Nanoscale apertures having islands of functionality May. 02, 2017
-
Patent Title: Integrated illumination of optical analytical devices Apr. 18, 2017
-
Patent Title: Arrays of integrated analytical devices Mar. 28, 2017
-
Patent Title: Methods and systems for obtaining a single molecule consensus sequence Mar. 21, 2017
-
Patent Title: Apparatus and method for performing nucleic acid analysis Mar. 07, 2017
-
Patent Title: Substrates, systems and methods for analyzing materials Mar. 07, 2017
-
Patent Title: Single molecule sequencing with two distinct chemistry steps Mar. 07, 2017
-
Patent Title: Methods for obtaining a single molecule consensus sequence Feb. 28, 2017
-
Patent Title: Analytical devices having compact lens train arrays Feb. 28, 2017
-
Patent Title: Intermittent detection during analytical reactions Jan. 31, 2017
-
Patent Title: Polymerases for nucleotide analogue incorporation Jan. 31, 2017
-
Patent Title: Method for detecting reactants using fluorescent signal intensity Jan. 24, 2017
-
Patent Title: Modular nucleotide compositions and uses therefor Jan. 24, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded to PACB from public contracts
Recent insights relating to PACB
Recent picks made for PACB stock on CNBC
ETFs with the largest estimated holdings in PACB
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $PACB stock a Buy, Sell, or Hold?
- What is the price target for $PACB stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $PACB stock?
- Who owns the most shares of $PACB stock?
- What funds own $PACB stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PACB Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
- Address Menlo Park, CA
- Market Cap 438.3 million
- Employees 485
- Industrial Classification Laboratory Analytical Instruments
Pacific Biosciences of California, Inc. (PACB) Historical Stock Prices
Pacific Biosciences of California, Inc. (PACB) closed at $1.47 on September 22, 2026. Over the past year its adjusted close ranged from $1.11 to $2.67. Daily prices go back to January 2, 2014, 3,199 trading days in all.
- 1 month+8.89%
- 3 months+12.21%
- Year to date-21.39%
- 1 year+13.95%
- 3 years-83.56%
- 5 years-94.66%
- Max-71.01%
Quiver Premium charts PACB's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | 1.38 | 1.48 | 1.36 | 1.47 | 1.47 | 7,848,551 |
| Sep 21, 2026 | 1.37 | 1.40 | 1.34 | 1.36 | 1.36 | 6,127,040 |
| Sep 18, 2026 | 1.38 | 1.40 | 1.34 | 1.37 | 1.37 | 4,959,562 |
| Sep 17, 2026 | 1.37 | 1.43 | 1.36 | 1.38 | 1.38 | 6,228,872 |
| Sep 16, 2026 | 1.34 | 1.40 | 1.32 | 1.34 | 1.34 | 5,319,722 |
| Sep 15, 2026 | 1.36 | 1.41 | 1.33 | 1.34 | 1.34 | 5,595,156 |
| Sep 14, 2026 | 1.28 | 1.38 | 1.28 | 1.35 | 1.35 | 4,719,790 |
| Sep 11, 2026 | 1.29 | 1.32 | 1.28 | 1.30 | 1.30 | 3,733,941 |
| Sep 10, 2026 | 1.26 | 1.31 | 1.25 | 1.27 | 1.27 | 4,707,775 |
| Sep 9, 2026 | 1.31 | 1.34 | 1.26 | 1.29 | 1.29 | 4,157,954 |
| Sep 8, 2026 | 1.34 | 1.36 | 1.30 | 1.32 | 1.32 | 3,988,702 |
| Sep 4, 2026 | 1.29 | 1.35 | 1.29 | 1.35 | 1.35 | 2,764,523 |
| Sep 3, 2026 | 1.33 | 1.35 | 1.28 | 1.30 | 1.30 | 5,151,172 |
| Sep 2, 2026 | 1.29 | 1.34 | 1.28 | 1.32 | 1.32 | 5,938,826 |
| Sep 1, 2026 | 1.33 | 1.34 | 1.28 | 1.28 | 1.28 | 6,036,619 |
| Aug 31, 2026 | 1.40 | 1.44 | 1.33 | 1.35 | 1.35 | 6,083,174 |
| Aug 28, 2026 | 1.52 | 1.54 | 1.39 | 1.40 | 1.40 | 5,228,724 |
| Aug 27, 2026 | 1.54 | 1.60 | 1.51 | 1.55 | 1.55 | 6,739,681 |
| Aug 26, 2026 | 1.52 | 1.61 | 1.47 | 1.56 | 1.56 | 7,859,558 |
| Aug 25, 2026 | 1.33 | 1.53 | 1.30 | 1.52 | 1.52 | 15,961,511 |
| Aug 24, 2026 | 1.35 | 1.35 | 1.26 | 1.28 | 1.28 | 5,584,759 |
| Aug 21, 2026 | 1.24 | 1.38 | 1.22 | 1.35 | 1.35 | 7,123,604 |
| Aug 20, 2026 | 1.26 | 1.32 | 1.22 | 1.23 | 1.23 | 4,761,742 |
| Aug 19, 2026 | 1.20 | 1.31 | 1.20 | 1.27 | 1.27 | 10,910,170 |
| Aug 18, 2026 | 1.19 | 1.21 | 1.12 | 1.14 | 1.14 | 4,817,953 |
| Aug 17, 2026 | 1.15 | 1.23 | 1.13 | 1.21 | 1.21 | 6,123,792 |
| Aug 14, 2026 | 1.15 | 1.18 | 1.12 | 1.15 | 1.15 | 3,933,012 |
| Aug 13, 2026 | 1.13 | 1.18 | 1.10 | 1.15 | 1.15 | 6,345,509 |
| Aug 12, 2026 | 1.15 | 1.16 | 1.07 | 1.11 | 1.11 | 13,295,179 |
| Aug 11, 2026 | 1.17 | 1.17 | 1.14 | 1.14 | 1.14 | 6,116,721 |
| Aug 10, 2026 | 1.16 | 1.19 | 1.12 | 1.15 | 1.15 | 7,843,950 |
| Aug 7, 2026 | 1.19 | 1.23 | 1.17 | 1.19 | 1.19 | 7,381,702 |
| Aug 6, 2026 | 1.30 | 1.31 | 1.15 | 1.17 | 1.17 | 14,531,308 |
| Aug 5, 2026 | 1.44 | 1.47 | 1.27 | 1.30 | 1.30 | 11,635,312 |
| Aug 4, 2026 | 1.44 | 1.47 | 1.41 | 1.44 | 1.44 | 6,396,543 |
| Aug 3, 2026 | 1.43 | 1.47 | 1.40 | 1.42 | 1.42 | 3,553,631 |
| Jul 31, 2026 | 1.47 | 1.48 | 1.39 | 1.40 | 1.40 | 3,139,195 |
| Jul 30, 2026 | 1.41 | 1.49 | 1.41 | 1.48 | 1.48 | 2,807,842 |
| Jul 29, 2026 | 1.38 | 1.47 | 1.38 | 1.40 | 1.40 | 7,337,925 |
| Jul 28, 2026 | 1.35 | 1.42 | 1.32 | 1.39 | 1.39 | 7,931,231 |
| Jul 27, 2026 | 1.36 | 1.41 | 1.34 | 1.36 | 1.36 | 6,750,944 |
| Jul 24, 2026 | 1.42 | 1.43 | 1.32 | 1.36 | 1.36 | 8,063,248 |
| Jul 23, 2026 | 1.36 | 1.43 | 1.36 | 1.40 | 1.40 | 6,861,412 |
| Jul 22, 2026 | 1.40 | 1.43 | 1.36 | 1.38 | 1.38 | 7,737,617 |
| Jul 21, 2026 | 1.35 | 1.42 | 1.33 | 1.40 | 1.40 | 7,438,666 |
| Jul 20, 2026 | 1.42 | 1.43 | 1.34 | 1.36 | 1.36 | 10,874,078 |
| Jul 17, 2026 | 1.45 | 1.49 | 1.43 | 1.44 | 1.44 | 7,078,875 |
| Jul 16, 2026 | 1.51 | 1.54 | 1.45 | 1.49 | 1.49 | 4,291,924 |
| Jul 15, 2026 | 1.50 | 1.55 | 1.48 | 1.53 | 1.53 | 3,552,632 |
| Jul 14, 2026 | 1.50 | 1.52 | 1.46 | 1.50 | 1.50 | 2,740,350 |
| Jul 13, 2026 | 1.53 | 1.56 | 1.47 | 1.49 | 1.49 | 5,397,032 |
| Jul 10, 2026 | 1.62 | 1.64 | 1.52 | 1.56 | 1.56 | 6,685,600 |
| Jul 9, 2026 | 1.51 | 1.68 | 1.50 | 1.61 | 1.61 | 6,137,150 |
| Jul 8, 2026 | 1.52 | 1.53 | 1.48 | 1.50 | 1.50 | 4,142,714 |
| Jul 7, 2026 | 1.66 | 1.67 | 1.54 | 1.56 | 1.56 | 3,669,266 |
| Jul 6, 2026 | 1.67 | 1.72 | 1.61 | 1.66 | 1.66 | 3,892,813 |
| Jul 2, 2026 | 1.73 | 1.83 | 1.67 | 1.68 | 1.68 | 5,375,171 |
| Jul 1, 2026 | 1.67 | 1.81 | 1.66 | 1.74 | 1.74 | 5,002,429 |
| Jun 30, 2026 | 1.73 | 1.75 | 1.60 | 1.68 | 1.68 | 6,885,072 |
| Jun 29, 2026 | 1.67 | 1.78 | 1.66 | 1.73 | 1.73 | 8,339,317 |
| Jun 26, 2026 | 1.58 | 1.71 | 1.56 | 1.65 | 1.65 | 19,180,262 |
| Jun 25, 2026 | 1.44 | 1.68 | 1.43 | 1.60 | 1.60 | 10,585,384 |
| Jun 24, 2026 | 1.31 | 1.48 | 1.31 | 1.44 | 1.44 | 6,200,663 |
| Jun 23, 2026 | 1.30 | 1.37 | 1.29 | 1.31 | 1.31 | 4,911,227 |
| Jun 22, 2026 | 1.38 | 1.41 | 1.32 | 1.32 | 1.32 | 4,545,818 |
| Jun 18, 2026 | 1.36 | 1.43 | 1.36 | 1.40 | 1.40 | 4,318,168 |
| Jun 17, 2026 | 1.35 | 1.45 | 1.34 | 1.34 | 1.34 | 4,798,086 |
| Jun 16, 2026 | 1.33 | 1.40 | 1.32 | 1.35 | 1.35 | 3,742,765 |
| Jun 15, 2026 | 1.34 | 1.39 | 1.30 | 1.32 | 1.32 | 5,298,162 |
| Jun 12, 2026 | 1.34 | 1.39 | 1.30 | 1.31 | 1.31 | 4,981,024 |
| Jun 11, 2026 | 1.35 | 1.37 | 1.31 | 1.35 | 1.35 | 5,069,275 |
| Jun 10, 2026 | 1.38 | 1.44 | 1.35 | 1.37 | 1.37 | 5,224,296 |
| Jun 9, 2026 | 1.40 | 1.44 | 1.31 | 1.37 | 1.37 | 3,834,133 |
| Jun 8, 2026 | 1.49 | 1.49 | 1.35 | 1.38 | 1.38 | 4,225,737 |
| Jun 5, 2026 | 1.60 | 1.62 | 1.39 | 1.45 | 1.45 | 6,483,684 |
| Jun 4, 2026 | 1.61 | 1.77 | 1.58 | 1.63 | 1.63 | 7,876,095 |
| Jun 3, 2026 | 1.57 | 1.60 | 1.49 | 1.58 | 1.58 | 6,842,352 |
| Jun 2, 2026 | 1.55 | 1.63 | 1.52 | 1.58 | 1.58 | 7,936,394 |
| Jun 1, 2026 | 1.45 | 1.62 | 1.44 | 1.58 | 1.58 | 8,207,767 |
| May 29, 2026 | 1.47 | 1.53 | 1.42 | 1.49 | 1.49 | 7,012,525 |
| May 28, 2026 | 1.30 | 1.48 | 1.29 | 1.47 | 1.47 | 9,354,394 |
| May 27, 2026 | 1.26 | 1.31 | 1.25 | 1.29 | 1.29 | 3,474,283 |
| May 26, 2026 | 1.24 | 1.28 | 1.19 | 1.26 | 1.26 | 6,286,898 |
| May 22, 2026 | 1.24 | 1.28 | 1.21 | 1.22 | 1.22 | 4,637,740 |
| May 21, 2026 | 1.18 | 1.27 | 1.17 | 1.25 | 1.25 | 3,981,227 |
| May 20, 2026 | 1.15 | 1.20 | 1.14 | 1.19 | 1.19 | 3,750,056 |
| May 19, 2026 | 1.16 | 1.19 | 1.12 | 1.15 | 1.15 | 5,193,567 |
| May 18, 2026 | 1.13 | 1.20 | 1.09 | 1.15 | 1.15 | 7,884,768 |
| May 15, 2026 | 1.21 | 1.21 | 1.12 | 1.12 | 1.12 | 9,318,967 |
| May 14, 2026 | 1.27 | 1.30 | 1.20 | 1.21 | 1.21 | 9,559,434 |
| May 13, 2026 | 1.28 | 1.32 | 1.25 | 1.27 | 1.27 | 4,997,868 |
| May 12, 2026 | 1.35 | 1.36 | 1.28 | 1.28 | 1.28 | 6,861,425 |
| May 11, 2026 | 1.42 | 1.45 | 1.35 | 1.35 | 1.35 | 4,670,154 |
| May 8, 2026 | 1.52 | 1.52 | 1.35 | 1.41 | 1.41 | 9,870,271 |
| May 7, 2026 | 1.70 | 1.76 | 1.63 | 1.65 | 1.65 | 6,321,819 |
| May 6, 2026 | 1.58 | 1.73 | 1.58 | 1.71 | 1.71 | 7,522,721 |
| May 5, 2026 | 1.55 | 1.58 | 1.50 | 1.58 | 1.58 | 5,805,954 |
| May 4, 2026 | 1.59 | 1.62 | 1.53 | 1.55 | 1.55 | 3,604,934 |
| May 1, 2026 | 1.59 | 1.62 | 1.53 | 1.60 | 1.60 | 5,002,572 |
| Apr 30, 2026 | 1.48 | 1.60 | 1.48 | 1.59 | 1.59 | 4,962,100 |
| Apr 29, 2026 | 1.56 | 1.56 | 1.42 | 1.47 | 1.47 | 5,892,336 |
| Apr 28, 2026 | 1.56 | 1.59 | 1.53 | 1.58 | 1.58 | 3,981,361 |
| Apr 27, 2026 | 1.54 | 1.68 | 1.53 | 1.59 | 1.59 | 7,248,173 |
| Apr 24, 2026 | 1.55 | 1.63 | 1.51 | 1.56 | 1.56 | 11,370,536 |
| Apr 23, 2026 | 1.68 | 1.69 | 1.55 | 1.57 | 1.57 | 9,691,320 |
| Apr 22, 2026 | 1.76 | 1.77 | 1.67 | 1.71 | 1.71 | 4,714,440 |
| Apr 21, 2026 | 1.74 | 1.80 | 1.67 | 1.73 | 1.73 | 8,036,437 |
| Apr 20, 2026 | 1.65 | 1.75 | 1.64 | 1.74 | 1.74 | 4,202,599 |
| Apr 17, 2026 | 1.70 | 1.75 | 1.66 | 1.69 | 1.69 | 8,531,515 |
| Apr 16, 2026 | 1.63 | 1.65 | 1.54 | 1.63 | 1.63 | 5,346,943 |
| Apr 15, 2026 | 1.52 | 1.64 | 1.52 | 1.60 | 1.60 | 4,352,036 |
| Apr 14, 2026 | 1.47 | 1.59 | 1.47 | 1.57 | 1.57 | 6,339,662 |
| Apr 13, 2026 | 1.33 | 1.46 | 1.33 | 1.45 | 1.45 | 4,765,842 |
| Apr 10, 2026 | 1.36 | 1.38 | 1.31 | 1.34 | 1.34 | 3,593,928 |
| Apr 9, 2026 | 1.47 | 1.47 | 1.35 | 1.35 | 1.35 | 5,580,315 |
| Apr 8, 2026 | 1.54 | 1.59 | 1.43 | 1.47 | 1.47 | 5,310,447 |
| Apr 7, 2026 | 1.39 | 1.47 | 1.36 | 1.44 | 1.44 | 4,274,928 |
| Apr 6, 2026 | 1.33 | 1.45 | 1.33 | 1.42 | 1.42 | 6,405,003 |
| Apr 2, 2026 | 1.30 | 1.36 | 1.28 | 1.34 | 1.34 | 6,492,594 |
| Apr 1, 2026 | 1.36 | 1.40 | 1.34 | 1.35 | 1.35 | 8,212,229 |
| Mar 31, 2026 | 1.27 | 1.34 | 1.27 | 1.32 | 1.32 | 9,644,220 |
| Mar 30, 2026 | 1.26 | 1.27 | 1.24 | 1.26 | 1.26 | 9,442,785 |
| Mar 27, 2026 | 1.34 | 1.35 | 1.23 | 1.26 | 1.26 | 8,686,680 |
| Mar 26, 2026 | 1.37 | 1.40 | 1.33 | 1.35 | 1.35 | 4,665,285 |
| Mar 25, 2026 | 1.41 | 1.45 | 1.36 | 1.39 | 1.39 | 2,942,099 |
| Mar 24, 2026 | 1.38 | 1.43 | 1.35 | 1.39 | 1.39 | 4,076,467 |
| Mar 23, 2026 | 1.35 | 1.42 | 1.35 | 1.39 | 1.39 | 4,608,610 |
| Mar 20, 2026 | 1.39 | 1.40 | 1.31 | 1.33 | 1.33 | 5,469,313 |
| Mar 19, 2026 | 1.30 | 1.43 | 1.28 | 1.40 | 1.40 | 4,465,453 |
| Mar 18, 2026 | 1.37 | 1.41 | 1.32 | 1.33 | 1.33 | 4,557,479 |
| Mar 17, 2026 | 1.37 | 1.43 | 1.36 | 1.38 | 1.38 | 3,050,504 |
| Mar 16, 2026 | 1.36 | 1.40 | 1.34 | 1.36 | 1.36 | 3,985,573 |
| Mar 13, 2026 | 1.30 | 1.39 | 1.29 | 1.33 | 1.33 | 5,082,346 |
| Mar 12, 2026 | 1.30 | 1.32 | 1.25 | 1.27 | 1.27 | 6,592,631 |
| Mar 11, 2026 | 1.38 | 1.41 | 1.34 | 1.35 | 1.35 | 4,759,583 |
| Mar 10, 2026 | 1.43 | 1.46 | 1.35 | 1.37 | 1.37 | 6,140,887 |
| Mar 9, 2026 | 1.35 | 1.39 | 1.32 | 1.39 | 1.39 | 6,349,474 |
| Mar 6, 2026 | 1.46 | 1.47 | 1.36 | 1.38 | 1.38 | 8,953,016 |
| Mar 5, 2026 | 1.54 | 1.56 | 1.50 | 1.52 | 1.52 | 4,597,898 |
| Mar 4, 2026 | 1.57 | 1.65 | 1.54 | 1.56 | 1.56 | 5,160,702 |
| Mar 3, 2026 | 1.57 | 1.57 | 1.49 | 1.52 | 1.52 | 9,438,327 |
| Mar 2, 2026 | 1.61 | 1.68 | 1.56 | 1.62 | 1.62 | 6,959,609 |
| Feb 27, 2026 | 1.74 | 1.75 | 1.65 | 1.68 | 1.68 | 5,295,087 |
| Feb 26, 2026 | 1.64 | 1.80 | 1.63 | 1.78 | 1.78 | 4,674,321 |
| Feb 25, 2026 | 1.68 | 1.71 | 1.62 | 1.63 | 1.63 | 4,137,111 |
| Feb 24, 2026 | 1.58 | 1.70 | 1.57 | 1.66 | 1.66 | 3,897,413 |
| Feb 23, 2026 | 1.61 | 1.65 | 1.54 | 1.58 | 1.58 | 6,575,554 |
| Feb 20, 2026 | 1.66 | 1.67 | 1.57 | 1.61 | 1.61 | 4,342,005 |
| Feb 19, 2026 | 1.61 | 1.71 | 1.58 | 1.68 | 1.68 | 4,311,519 |
| Feb 18, 2026 | 1.59 | 1.71 | 1.54 | 1.63 | 1.63 | 7,654,931 |
| Feb 17, 2026 | 1.68 | 1.69 | 1.51 | 1.58 | 1.58 | 11,703,353 |
| Feb 13, 2026 | 1.89 | 2.00 | 1.65 | 1.71 | 1.71 | 9,120,296 |
| Feb 12, 2026 | 1.85 | 1.92 | 1.76 | 1.84 | 1.84 | 9,520,021 |
| Feb 11, 2026 | 1.82 | 1.84 | 1.72 | 1.84 | 1.84 | 6,163,448 |
| Feb 10, 2026 | 1.86 | 1.90 | 1.80 | 1.81 | 1.81 | 4,695,289 |
| Feb 9, 2026 | 1.82 | 1.85 | 1.77 | 1.84 | 1.84 | 4,771,645 |
| Feb 6, 2026 | 1.80 | 1.86 | 1.69 | 1.82 | 1.82 | 7,137,070 |
| Feb 5, 2026 | 1.91 | 1.95 | 1.68 | 1.72 | 1.72 | 9,609,487 |
| Feb 4, 2026 | 2.02 | 2.05 | 1.89 | 1.95 | 1.95 | 8,378,071 |
| Feb 3, 2026 | 2.09 | 2.15 | 1.96 | 2.04 | 2.04 | 6,980,006 |
| Feb 2, 2026 | 2.25 | 2.27 | 2.03 | 2.06 | 2.06 | 8,683,189 |
| Jan 30, 2026 | 2.32 | 2.36 | 2.20 | 2.26 | 2.26 | 8,586,039 |
| Jan 29, 2026 | 2.36 | 2.42 | 2.30 | 2.37 | 2.37 | 9,095,524 |
| Jan 28, 2026 | 2.58 | 2.60 | 2.37 | 2.38 | 2.38 | 7,485,697 |
| Jan 27, 2026 | 2.52 | 2.58 | 2.41 | 2.57 | 2.57 | 8,705,502 |
| Jan 26, 2026 | 2.54 | 2.58 | 2.45 | 2.52 | 2.52 | 6,346,288 |
| Jan 23, 2026 | 2.67 | 2.73 | 2.56 | 2.58 | 2.58 | 6,820,294 |
| Jan 22, 2026 | 2.46 | 2.69 | 2.43 | 2.67 | 2.67 | 10,221,020 |
| Jan 21, 2026 | 2.38 | 2.46 | 2.24 | 2.42 | 2.42 | 8,673,933 |
| Jan 20, 2026 | 2.10 | 2.40 | 2.09 | 2.36 | 2.36 | 12,224,981 |
| Jan 16, 2026 | 2.34 | 2.40 | 2.21 | 2.21 | 2.21 | 6,201,701 |
| Jan 15, 2026 | 2.35 | 2.38 | 2.18 | 2.35 | 2.35 | 6,707,669 |
| Jan 14, 2026 | 2.13 | 2.37 | 2.12 | 2.36 | 2.36 | 11,628,897 |
| Jan 13, 2026 | 2.03 | 2.18 | 2.03 | 2.13 | 2.13 | 9,399,128 |
| Jan 12, 2026 | 1.96 | 2.12 | 1.84 | 2.01 | 2.01 | 10,723,423 |
| Jan 9, 2026 | 2.06 | 2.12 | 1.93 | 1.94 | 1.94 | 11,465,618 |
| Jan 8, 2026 | 2.13 | 2.13 | 1.98 | 2.04 | 2.04 | 6,793,555 |
| Jan 7, 2026 | 2.07 | 2.22 | 2.05 | 2.13 | 2.13 | 8,284,446 |
| Jan 6, 2026 | 2.01 | 2.12 | 2.00 | 2.08 | 2.08 | 6,905,012 |
| Jan 5, 2026 | 1.86 | 1.99 | 1.84 | 1.98 | 1.98 | 8,490,696 |
| Jan 2, 2026 | 1.95 | 1.97 | 1.79 | 1.84 | 1.84 | 8,175,846 |
| Dec 31, 2025 | 1.76 | 1.88 | 1.75 | 1.87 | 1.87 | 7,065,747 |
| Dec 30, 2025 | 1.72 | 1.76 | 1.70 | 1.73 | 1.73 | 5,974,569 |
| Dec 29, 2025 | 1.73 | 1.78 | 1.67 | 1.71 | 1.71 | 5,806,891 |
| Dec 26, 2025 | 1.88 | 1.88 | 1.76 | 1.77 | 1.77 | 4,951,155 |
| Dec 24, 2025 | 1.81 | 1.89 | 1.80 | 1.88 | 1.88 | 3,425,396 |
| Dec 23, 2025 | 1.83 | 1.86 | 1.77 | 1.82 | 1.82 | 6,108,248 |
| Dec 22, 2025 | 1.84 | 1.87 | 1.81 | 1.82 | 1.82 | 8,290,949 |
| Dec 19, 2025 | 1.89 | 1.92 | 1.82 | 1.84 | 1.84 | 9,040,225 |
| Dec 18, 2025 | 1.97 | 2.05 | 1.86 | 1.88 | 1.88 | 8,373,674 |
| Dec 17, 2025 | 2.02 | 2.07 | 1.91 | 1.93 | 1.93 | 6,104,906 |
| Dec 16, 2025 | 2.08 | 2.13 | 1.98 | 2.02 | 2.02 | 5,765,229 |
| Dec 15, 2025 | 2.15 | 2.17 | 2.06 | 2.12 | 2.12 | 3,737,106 |
| Dec 12, 2025 | 2.15 | 2.19 | 2.11 | 2.12 | 2.12 | 4,643,116 |
| Dec 11, 2025 | 2.37 | 2.45 | 2.16 | 2.17 | 2.17 | 7,115,588 |
| Dec 10, 2025 | 2.40 | 2.47 | 2.33 | 2.37 | 2.37 | 5,942,385 |
| Dec 9, 2025 | 2.32 | 2.44 | 2.31 | 2.43 | 2.43 | 4,881,762 |
| Dec 8, 2025 | 2.38 | 2.48 | 2.31 | 2.32 | 2.32 | 4,315,132 |
| Dec 5, 2025 | 2.52 | 2.55 | 2.32 | 2.39 | 2.39 | 8,397,425 |
| Dec 4, 2025 | 2.43 | 2.58 | 2.30 | 2.52 | 2.52 | 8,249,148 |
| Dec 3, 2025 | 2.33 | 2.44 | 2.31 | 2.43 | 2.43 | 8,698,264 |
| Dec 2, 2025 | 2.22 | 2.37 | 2.22 | 2.32 | 2.32 | 6,612,506 |
| Dec 1, 2025 | 2.23 | 2.30 | 2.20 | 2.23 | 2.23 | 7,059,188 |
| Nov 28, 2025 | 2.36 | 2.38 | 2.29 | 2.32 | 2.32 | 3,717,914 |
| Nov 26, 2025 | 2.63 | 2.64 | 2.24 | 2.39 | 2.39 | 12,238,079 |
| Nov 25, 2025 | 2.47 | 2.73 | 2.42 | 2.63 | 2.63 | 15,001,817 |
| Nov 24, 2025 | 2.19 | 2.52 | 2.18 | 2.50 | 2.50 | 18,884,559 |
| Nov 21, 2025 | 1.85 | 2.23 | 1.83 | 2.22 | 2.22 | 21,197,118 |
| Nov 20, 2025 | 1.82 | 2.09 | 1.81 | 1.88 | 1.88 | 13,224,752 |
| Nov 19, 2025 | 1.65 | 1.81 | 1.63 | 1.76 | 1.76 | 5,598,871 |
| Nov 18, 2025 | 1.55 | 1.67 | 1.52 | 1.65 | 1.65 | 6,148,001 |
| Nov 17, 2025 | 1.61 | 1.65 | 1.54 | 1.57 | 1.57 | 4,336,986 |
| Nov 14, 2025 | 1.54 | 1.67 | 1.53 | 1.61 | 1.61 | 5,208,207 |
| Nov 13, 2025 | 1.72 | 1.73 | 1.61 | 1.63 | 1.63 | 6,567,609 |
| Nov 12, 2025 | 1.87 | 1.91 | 1.72 | 1.74 | 1.74 | 5,553,104 |
| Nov 11, 2025 | 1.78 | 1.87 | 1.74 | 1.86 | 1.86 | 5,384,468 |
| Nov 10, 2025 | 1.83 | 1.89 | 1.75 | 1.76 | 1.76 | 6,616,061 |
| Nov 7, 2025 | 1.76 | 1.79 | 1.63 | 1.76 | 1.76 | 8,352,934 |
| Nov 6, 2025 | 1.80 | 1.98 | 1.76 | 1.78 | 1.78 | 20,826,987 |
| Nov 5, 2025 | 2.08 | 2.10 | 1.91 | 1.92 | 1.92 | 11,888,348 |
| Nov 4, 2025 | 2.18 | 2.21 | 1.99 | 2.00 | 2.00 | 11,540,886 |
| Nov 3, 2025 | 2.34 | 2.34 | 2.16 | 2.24 | 2.24 | 11,683,967 |
| Oct 31, 2025 | 2.06 | 2.37 | 2.05 | 2.34 | 2.34 | 22,749,415 |
| Oct 30, 2025 | 1.99 | 2.05 | 1.91 | 1.94 | 1.94 | 8,801,913 |
| Oct 29, 2025 | 1.98 | 2.05 | 1.97 | 2.01 | 2.01 | 9,548,058 |
| Oct 28, 2025 | 2.12 | 2.13 | 1.93 | 1.97 | 1.97 | 9,162,876 |
| Oct 27, 2025 | 2.06 | 2.13 | 1.97 | 2.09 | 2.09 | 10,332,683 |
| Oct 24, 2025 | 1.99 | 2.08 | 1.99 | 2.02 | 2.02 | 12,079,837 |
| Oct 23, 2025 | 1.83 | 1.97 | 1.81 | 1.95 | 1.95 | 9,211,486 |
| Oct 22, 2025 | 1.89 | 1.90 | 1.71 | 1.84 | 1.84 | 10,802,331 |
| Oct 21, 2025 | 1.92 | 2.00 | 1.86 | 1.90 | 1.90 | 9,164,639 |
| Oct 20, 2025 | 1.69 | 2.00 | 1.68 | 1.98 | 1.98 | 18,588,567 |
| Oct 17, 2025 | 1.73 | 1.77 | 1.63 | 1.64 | 1.64 | 7,149,453 |
| Oct 16, 2025 | 1.75 | 1.84 | 1.73 | 1.76 | 1.76 | 9,525,065 |
| Oct 15, 2025 | 1.63 | 1.77 | 1.62 | 1.74 | 1.74 | 13,899,378 |
| Oct 14, 2025 | 1.57 | 1.61 | 1.51 | 1.59 | 1.59 | 8,017,626 |
| Oct 13, 2025 | 1.45 | 1.62 | 1.42 | 1.62 | 1.62 | 13,886,927 |
| Oct 10, 2025 | 1.56 | 1.56 | 1.37 | 1.42 | 1.42 | 8,751,995 |
| Oct 9, 2025 | 1.54 | 1.59 | 1.49 | 1.53 | 1.53 | 7,166,063 |
| Oct 8, 2025 | 1.44 | 1.55 | 1.41 | 1.51 | 1.51 | 8,061,601 |
| Oct 7, 2025 | 1.53 | 1.53 | 1.39 | 1.40 | 1.40 | 5,830,593 |
| Oct 6, 2025 | 1.51 | 1.56 | 1.47 | 1.52 | 1.52 | 5,800,546 |
| Oct 3, 2025 | 1.43 | 1.53 | 1.42 | 1.49 | 1.49 | 7,340,899 |
| Oct 2, 2025 | 1.40 | 1.44 | 1.36 | 1.43 | 1.43 | 5,635,198 |
| Oct 1, 2025 | 1.26 | 1.40 | 1.26 | 1.38 | 1.38 | 8,388,233 |
| Sep 30, 2025 | 1.26 | 1.30 | 1.23 | 1.28 | 1.28 | 5,288,949 |
| Sep 29, 2025 | 1.23 | 1.27 | 1.20 | 1.25 | 1.25 | 5,707,406 |
| Sep 26, 2025 | 1.22 | 1.24 | 1.19 | 1.21 | 1.21 | 4,702,814 |
| Sep 25, 2025 | 1.23 | 1.25 | 1.20 | 1.22 | 1.22 | 4,921,316 |
| Sep 24, 2025 | 1.30 | 1.31 | 1.24 | 1.25 | 1.25 | 4,932,431 |
| Sep 23, 2025 | 1.29 | 1.31 | 1.26 | 1.29 | 1.29 | 6,749,129 |
| Sep 22, 2025 | 1.27 | 1.30 | 1.24 | 1.29 | 1.29 | 6,558,767 |
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver APIWe estimate that -- received a compensation of -- in --, making them the highest paid executive at PACB, per a recent SEC DEF 14A filing. We estimate that the median employee at PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is paid $199,372.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|